Recent research sheds light on how changes in the chemical structure of a protein called Interleukin-6 affect lung cancer’s ...

pCRP is the well-established systemic marker of inflammation, while mCRP is associated with localized tissue inflammation.Methods: This study aimed to evaluate systemic levels of pCRP, mCRP, ...

Background Targeting interleukin (IL)-6 has become a major therapeutic strategy in the treatment of immune-mediated inflammatory disease. Interference with the IL-6 pathway can be directed at the ...

This newly identified pathway suggests that apathy is not merely a byproduct of physical deterioration ... they mapped brain activity in mice with the condition and pinpointed a set of neurons in the ...

Background: Interleukin-6 (IL-6) is a key proinflammatory cytokine regulating the humoral immune response by inducing B lymphocyte differentiation into plasma cells and stimulating antibody production ...

Scientists identify a brain pathway linking inflammation to fatigue, low energy, and loss of motivation in advanced cancer patients.

Dopamine maintains hope and motivation for life. Inflammation-associated compounds disrupt dopamine release, causing apathy.

Researchers identified a direct connection between cancer-related inflammation and the loss of motivation characteristic of advanced cancer. In a mouse study, they describe a brain pathway that starts ...

University of Chicago, Chicago, IL.

Convenient snacks contribute to chronic inflammation, leading to various diseases; anti-inflammatory diet and lifestyle ...

In the Phase III SELECT-GCA trial, Rinvoq (upadacitinib) 15 mg with a 26-week glucocorticoid taper significantly improved ...